Triple negative breast cancer: special histological types and emerging therapeutic methods

Triple negative breast cancer (TNBC) is a complex and malignant breast cancer subtype that lacks expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), thereby making therapeutic targeting difficult. TNBC is generally considered to h...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lu, Niu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309458/
https://www.ncbi.nlm.nih.gov/pubmed/32587770
http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309458/
https://www.ncbi.nlm.nih.gov/pubmed/32587770
http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0465

Ejemplares similares